Nelotanserin Completed Phase 2 Trials for Dementia With Lewy Body Disease / Visual Hallucinations Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02640729Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia